Diode laser transscleral cyclophotocoagulation as a primary surgical treatment for primary open-angle glaucoma
To evaluate the feasibility of diode laser transscleral cyclophotocoagulation (TSCPC) as a primary surgical treatment for primary open-angle glaucoma and to compare 2 laser energy settings used for treatment. In a prospective clinical trial in Cape Coast and Accra, Ghana, 1 eye of each of 92 patient...
Saved in:
Published in | Archives of ophthalmology (1960) Vol. 119; no. 3; p. 345 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
United States
01.03.2001
|
Subjects | |
Online Access | Get more information |
Cover
Loading…
Abstract | To evaluate the feasibility of diode laser transscleral cyclophotocoagulation (TSCPC) as a primary surgical treatment for primary open-angle glaucoma and to compare 2 laser energy settings used for treatment.
In a prospective clinical trial in Cape Coast and Accra, Ghana, 1 eye of each of 92 patients with primary open-angle glaucoma was treated by diode laser TSCPC as a primary surgical treatment. Eyes were randomly assigned to receive treatment by 20 applications of either 1.5 W applied for 1.5 seconds or 1.25 W applied for 2.5 seconds.
Seventy-nine (86%) of 92 patients completed 3 months of follow-up; follow-up was 13.2 +/- 6.0 months (mean +/- SD). Intraocular pressure decreased in 53 (67%) of the 79 eyes. The drop in intraocular pressure was 20% or more in 37 eyes (47%) and final intraocular pressure was 22 mm Hg or less in 38 eyes (48%). An atonic pupil was a previously unreported complication that arose in 27 (28%) of 92 eyes. There were no serious complications of hypotony, phthisis bulbi, or sympathetic ophthalmia. Visual acuity decreased in 18 (23%) of 79 eyes treated by TSCPC and in 10 (23%) of 47 fellow eyes treated only with glaucoma medications. There was no difference in outcomes between the 2 laser energy settings.
Diode laser TSCPC is a practical, rapid, well-tolerated procedure that may provide a modest and variable lowering of intraocular pressure. The treatment, used with conservative energy levels applied to the eye, seems to have few serious complications, although a previously unrecognized complication of atonic pupil needs further evaluation. A moderate variation in laser energy settings does not influence the results of treatment. |
---|---|
AbstractList | To evaluate the feasibility of diode laser transscleral cyclophotocoagulation (TSCPC) as a primary surgical treatment for primary open-angle glaucoma and to compare 2 laser energy settings used for treatment.
In a prospective clinical trial in Cape Coast and Accra, Ghana, 1 eye of each of 92 patients with primary open-angle glaucoma was treated by diode laser TSCPC as a primary surgical treatment. Eyes were randomly assigned to receive treatment by 20 applications of either 1.5 W applied for 1.5 seconds or 1.25 W applied for 2.5 seconds.
Seventy-nine (86%) of 92 patients completed 3 months of follow-up; follow-up was 13.2 +/- 6.0 months (mean +/- SD). Intraocular pressure decreased in 53 (67%) of the 79 eyes. The drop in intraocular pressure was 20% or more in 37 eyes (47%) and final intraocular pressure was 22 mm Hg or less in 38 eyes (48%). An atonic pupil was a previously unreported complication that arose in 27 (28%) of 92 eyes. There were no serious complications of hypotony, phthisis bulbi, or sympathetic ophthalmia. Visual acuity decreased in 18 (23%) of 79 eyes treated by TSCPC and in 10 (23%) of 47 fellow eyes treated only with glaucoma medications. There was no difference in outcomes between the 2 laser energy settings.
Diode laser TSCPC is a practical, rapid, well-tolerated procedure that may provide a modest and variable lowering of intraocular pressure. The treatment, used with conservative energy levels applied to the eye, seems to have few serious complications, although a previously unrecognized complication of atonic pupil needs further evaluation. A moderate variation in laser energy settings does not influence the results of treatment. |
Author | Egbert, P R Dadzie, P Byrd, S Budenz, D L Fiadoyor, S |
Author_xml | – sequence: 1 givenname: P R surname: Egbert fullname: Egbert, P R email: egbert@stanford.edu organization: Department of Ophthalmology, Stanford University Medical Center, Room A 157, Stanford, CA 94305-5308. egbert@stanford.edu – sequence: 2 givenname: S surname: Fiadoyor fullname: Fiadoyor, S – sequence: 3 givenname: D L surname: Budenz fullname: Budenz, D L – sequence: 4 givenname: P surname: Dadzie fullname: Dadzie, P – sequence: 5 givenname: S surname: Byrd fullname: Byrd, S |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/11231767$$D View this record in MEDLINE/PubMed |
BookMark | eNo9T0tLxDAYzGHFfegf8CD5A635kr5ylPUJC170vHxNk24lTUqSHvbfW3CVOQzDDMPMlqycd5qQO2A5MAYPGNTJT6eUA8hc5KIoV2TDGBOZlCVbk22M34usgMlrsgbgAuqq3hD3NPhOU4tRB5oCuhiV1QEtVWdll0afvPLYzxbT4B3FSJFOYRgxnGmcQz-oJZuCxjRql6jx4d_2k3YZut5q2luclR_xhlwZtFHfXnhHvl6eP_dv2eHj9X3_eMiwEE3KoJalYkXNi6JrWyEN590CLjlH0Aa6QiEzooRKs7YEXYpS6qYSBnhlmkbyHbn_7Z3mdtTd8TLp-Hec_wCj4F5d |
CitedBy_id | crossref_primary_10_2147_OPTH_S447875 crossref_primary_10_3928_23258160_20130503_06 crossref_primary_10_1007_s00417_016_3563_z crossref_primary_10_1007_s00347_018_0677_1 crossref_primary_10_1111_cxo_13114 crossref_primary_10_1007_s00417_010_1363_4 crossref_primary_10_3390_vision1040024 crossref_primary_10_3109_08820538_2016_1154163 crossref_primary_10_1046_j_1442_9071_2003_00777_x crossref_primary_10_1007_s10792_019_01093_w crossref_primary_10_1007_s00347_017_0609_5 crossref_primary_10_1007_s10384_022_00938_9 crossref_primary_10_1016_j_preteyeres_2020_100879 crossref_primary_10_1078_1615_1615_00079 crossref_primary_10_1002_lsm_22202 crossref_primary_10_1097_00061198_200406000_00011 crossref_primary_10_1586_eop_09_66 crossref_primary_10_1097_IJG_0000000000001552 crossref_primary_10_1016_j_ophtha_2024_01_014 crossref_primary_10_1097_IJG_0000000000000503 crossref_primary_10_1007_s10103_019_02922_1 crossref_primary_10_1038_sj_eye_6702345 crossref_primary_10_1111_aos_15754 crossref_primary_10_1097_00055735_200404000_00011 crossref_primary_10_1097_IIO_0000000000000235 crossref_primary_10_1111_ceo_12558 crossref_primary_10_1097_IJG_0000000000000370 crossref_primary_10_3390_jcm9072039 crossref_primary_10_1007_s00417_015_3159_z crossref_primary_10_1111_aos_14661 crossref_primary_10_1007_s00417_013_2441_1 crossref_primary_10_1016_j_ajoc_2024_102072 crossref_primary_10_1038_sj_eye_6700178 crossref_primary_10_1016_j_ophtha_2020_06_051 crossref_primary_10_1111_aos_12913 crossref_primary_10_21516_2072_0076_2024_17_1_136_143 crossref_primary_10_3928_1542_8877_20050701_04 crossref_primary_10_1016_j_jfo_2016_10_013 crossref_primary_10_1007_s12325_016_0330_9 crossref_primary_10_1007_s10792_018_0834_1 crossref_primary_10_1097_ICO_0b013e318156d1eb crossref_primary_10_1097_IJG_0000000000001057 crossref_primary_10_1016_j_jcjo_2021_01_015 crossref_primary_10_1097_IJG_0000000000001339 crossref_primary_10_1038_eye_2012_269 crossref_primary_10_1097_ICU_0b013e32835d9335 crossref_primary_10_1136_bmjopen_2013_002793 crossref_primary_10_1097_IJG_0000000000001008 crossref_primary_10_1111_aos_14125 crossref_primary_10_5301_ejo_5000389 crossref_primary_10_3109_08820538_2013_874487 crossref_primary_10_1080_08820538_2023_2168489 crossref_primary_10_1007_s10792_021_01893_z crossref_primary_10_1097_00061198_200208000_00009 crossref_primary_10_1007_s00417_006_0280_z crossref_primary_10_15406_mojcr_2018_08_00244 crossref_primary_10_1016_j_ogla_2018_08_007 crossref_primary_10_1007_s00417_021_05436_1 crossref_primary_10_1002_14651858_CD009313_pub2 crossref_primary_10_1016_j_ogla_2020_04_004 crossref_primary_10_1111_j_1442_9071_2006_01368_x crossref_primary_10_1016_j_jnma_2021_12_005 crossref_primary_10_1080_17469899_2022_2108790 crossref_primary_10_1046_j_1442_9071_2002_00553_x crossref_primary_10_1097_01_ijg_0000151890_41239_c5 crossref_primary_10_1016_j_ajo_2021_04_003 crossref_primary_10_1016_j_jcjo_2016_07_013 crossref_primary_10_1097_IJG_0000000000002284 crossref_primary_10_1136_bjophthalmol_2021_319757 crossref_primary_10_1097_IJG_0000000000000666 crossref_primary_10_1080_09286586_2018_1501499 crossref_primary_10_1097_IJG_0000000000001997 crossref_primary_10_3341_jkos_2022_63_2_183 crossref_primary_10_1111_aos_16652 crossref_primary_10_1080_08820538_2022_2152702 crossref_primary_10_1089_10445470152612026 crossref_primary_10_1097_IJG_0b013e31815f2539 crossref_primary_10_1111_ceo_13328 crossref_primary_10_1016_j_jfo_2021_06_006 crossref_primary_10_1016_j_ophtha_2003_11_008 crossref_primary_10_4137_OED_S4909 crossref_primary_10_1046_j_1442_9071_2004_00754_x crossref_primary_10_1007_s00417_021_05157_5 crossref_primary_10_1080_17469899_2021_1951232 crossref_primary_10_1097_00061198_200108000_00016 crossref_primary_10_1097_APO_0000000000000294 crossref_primary_10_1002_14651858_CD012223_pub2 crossref_primary_10_1097_IJG_0000000000001023 crossref_primary_10_1097_IJG_0000000000002079 crossref_primary_10_1177_11206721221149514 crossref_primary_10_1097_IJG_0000000000001426 crossref_primary_10_1097_IJG_0000000000002237 crossref_primary_10_1007_s00417_006_0421_4 crossref_primary_10_17816_OV11132 crossref_primary_10_1111_ceo_12088 crossref_primary_10_1016_j_sjopt_2009_12_002 crossref_primary_10_1097_00061198_200308000_00011 crossref_primary_10_3109_02656736_2014_984777 crossref_primary_10_1111_j_1600_0420_2006_00746_x crossref_primary_10_1016_j_ogla_2019_02_002 crossref_primary_10_1080_08820538_2019_1638946 crossref_primary_10_1111_ceo_12360 crossref_primary_10_1007_s00417_007_0708_0 crossref_primary_10_1002_14651858_CD004399_pub3 crossref_primary_10_3341_jkos_2015_56_11_1759 crossref_primary_10_1016_j_survophthal_2019_01_001 crossref_primary_10_1097_IJG_0000000000002346 crossref_primary_10_1016_S0161_6420_02_01019_9 crossref_primary_10_4103_tjosr_tjosr_27_22 crossref_primary_10_1097_00061198_200206000_00007 crossref_primary_10_1007_s00417_021_05468_7 crossref_primary_10_1007_s00717_008_0267_8 crossref_primary_10_1007_s11701_013_0424_1 crossref_primary_10_1016_j_pdpdt_2021_102580 crossref_primary_10_1016_j_ogla_2020_12_014 |
ContentType | Journal Article |
DBID | CGR CUY CVF ECM EIF NPM |
DOI | 10.1001/archopht.119.3.345 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) |
DatabaseTitleList | MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | no_fulltext_linktorsrc |
Discipline | Medicine |
ExternalDocumentID | 11231767 |
Genre | Comparative Study Clinical Trial Evaluation Studies Randomized Controlled Trial Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- -QF .55 .XZ 23N 2CT 2WC 354 39C 3O- 4.4 53G 5GY 6J9 AAWTL ABCQX ABJNI ABOCM ACGFS ADBBV AFFNX ALMA_UNASSIGNED_HOLDINGS AMJDE ARBJA BAWUL BCGUY BRYMA C1A C45 CGR CS3 CUY CVF EAM EBS ECM EIF EJD EMOBN EX3 F5P L7B MJL N4W N9A NPM OB3 OBH OGROG OHH OVD P2P RAJ SJN SV3 TEORI WH7 WOW X7M XHN YOC ZGI ZXP ZY1 |
ID | FETCH-LOGICAL-a438t-1795c047244dbb39f22d2d22922a1ef1d4ca0f3516e0b51e5359e863f126f8892 |
ISSN | 0003-9950 |
IngestDate | Sat Sep 28 08:38:47 EDT 2024 |
IsPeerReviewed | false |
IsScholarly | false |
Issue | 3 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-a438t-1795c047244dbb39f22d2d22922a1ef1d4ca0f3516e0b51e5359e863f126f8892 |
PMID | 11231767 |
ParticipantIDs | pubmed_primary_11231767 |
PublicationCentury | 2000 |
PublicationDate | 2001-03-01 |
PublicationDateYYYYMMDD | 2001-03-01 |
PublicationDate_xml | – month: 03 year: 2001 text: 2001-03-01 day: 01 |
PublicationDecade | 2000 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Archives of ophthalmology (1960) |
PublicationTitleAlternate | Arch Ophthalmol |
PublicationYear | 2001 |
References | 11231776 - Arch Ophthalmol. 2001 Mar;119(3):424-5 |
References_xml | |
SSID | ssj0006109 |
Score | 1.7231371 |
Snippet | To evaluate the feasibility of diode laser transscleral cyclophotocoagulation (TSCPC) as a primary surgical treatment for primary open-angle glaucoma and to... |
SourceID | pubmed |
SourceType | Index Database |
StartPage | 345 |
SubjectTerms | Adult Aged Aged, 80 and over Ciliary Body - surgery Feasibility Studies Female Glaucoma, Open-Angle - surgery Humans Intraocular Pressure Laser Coagulation Male Middle Aged Postoperative Complications Prospective Studies Reoperation Sclera Treatment Outcome Visual Acuity |
Title | Diode laser transscleral cyclophotocoagulation as a primary surgical treatment for primary open-angle glaucoma |
URI | https://www.ncbi.nlm.nih.gov/pubmed/11231767 |
Volume | 119 |
hasFullText | |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LS8NAEF6qgngR32_Zg7eSYrJJmj2qbRGhxYOCN9lNdmuhJqVND-3f8A87k2zSWB-oFELJpOkm82UyM8x8Q8iFVjySyg4sDb5olq2yAo4VAEKKJgQktmLY79zt-beP7t2T91SrvVWqlqapbITzL_tK_qNV2Ad6xS7ZP2i2PCnsgO-gX9iChmH7Kx23Bkmk6uD_qjHOeognEzgAO-7DWThMRi9JmoSJ6JsJXThSRtRHhl5iMh3nRm9Rao4Vh4UYp2pZIu4PVR0c7CmsXlT92CphLfxR-iKGrzmbExI_QbxSyTC0-9I0Bt0vyhM7AxEls-Tj1K9r5NnMMtqtepmUboloPqi0ohUpikqNVml2mcV5zjBbml1jKgfVsDwzoiwnmPxk3POhAvj844WBsecN1lg6GBQ0es3UDY4k-Eb5rI-fpUuE24Vohaw0AzSdPUwAmZc7stMXQxjxikwfFhJZfV4YMtKaky1FLZn38rBFNk3YQa9yDG2Tmop3yHrXFFbskjiDEs2gRKtQol9CiYoJFdRghRZQoiWUKECpFC-gRAso7ZHHTvvh5tYyozgs4bIgRRJbL0RiUdeNpGRcO04EH4c7jrCVtiM3FJeaebavLqVnK495XAU-07bj6yDgzj5ZjZNYHRJqN7GsQIfgqkuXuY7gSnAfrQT8KgijI3KQ36lns8zn4h4efys5IRsL3J2SNQ0PuDoDbzGV55n-3gF5nWoy |
link.rule.ids | 783 |
linkProvider | National Library of Medicine |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Diode+laser+transscleral+cyclophotocoagulation+as+a+primary+surgical+treatment+for+primary+open-angle+glaucoma&rft.jtitle=Archives+of+ophthalmology+%281960%29&rft.au=Egbert%2C+P+R&rft.au=Fiadoyor%2C+S&rft.au=Budenz%2C+D+L&rft.au=Dadzie%2C+P&rft.date=2001-03-01&rft.issn=0003-9950&rft.volume=119&rft.issue=3&rft.spage=345&rft_id=info:doi/10.1001%2Farchopht.119.3.345&rft_id=info%3Apmid%2F11231767&rft_id=info%3Apmid%2F11231767&rft.externalDocID=11231767 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0003-9950&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0003-9950&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0003-9950&client=summon |